Labshake search
Citations for Stemcell Technologies :
101 - 150 of 226 citations for 4 4' Bi 7H benz de anthracene 7 7' dione since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genomics 2020Quote: ... The cells were passaged every 3–4 days using Accutase (Stemcell Technologies). The iPS cells conversion to EPS as previous reported47.
-
bioRxiv - Microbiology 2022Quote: ... PneumaCult ALI medium supplemented with 4 μg/mL heparin (Stem Cell Technologies), 5 μM hydrocortisone ...
-
bioRxiv - Cell Biology 2024Quote: ... Passaging was performed every 3-4 days using ReLeSR (Stemcell Technologies, #05872) according to manufacturer’s instructions ...
-
bioRxiv - Genomics 2022Quote: ... 4 mL of 29% Iodoxanol cushion was prepared with OptiPrep (Stemcell Technologies) and diluent medium (250 mM sucrose ...
-
Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa CF clinical isolatesbioRxiv - Microbiology 2023Quote: ... 480 ng/mL hydrocortisone and 4 µg/mL heparin (STEMCELL Technologies, 07980). ALI cultures were grown in a 37 °C ...
-
bioRxiv - Cell Biology 2024Quote: ... Passaging was performed every 3-4 days using ReLeSR (Stemcell Technologies, #05872) according to manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2024Quote: ... and passaged every 3-4 days using Accutase (Stem Cell Technologies, # 07920) The detailed procedure can be found in previous studies28.
-
bioRxiv - Cell Biology 2020Quote: ... at 8.8µg/cm2 and passaged every 4 days using ReLeSR (Stem Cell Technologies). All hPSCs experiments were conducted with cells ranging from 40 and 70 passages ...
-
bioRxiv - Developmental Biology 2021Quote: ... and cells were routinely passaged every 4 days using ReleSR (StemCell Technologies; 05872). CRISPRi-SOX2 cells were plated on vitronectin-coated (ThermoFisher ...
-
bioRxiv - Bioengineering 2021Quote: ... 4 million hiPSC were seeded into an AggreWell 800 well (Stem Cell Technologies) to generate embryoid bodies (EBs ...
-
bioRxiv - Bioengineering 2021Quote: ... single cells suspended in a 3:4 mixture of Mammocult (StemCell Technologies 05620) and Matrigel (Corning 354234 ...
-
bioRxiv - Molecular Biology 2024Quote: ... inhibition of canonical Wnt signaling is performed using IWP-4 (#72552, STEMCELL Technologies) a Wnt signaling inhibitor ...
-
bioRxiv - Molecular Biology 2023Quote: ... Every 4-5 days cells were passaged using ReLeSR reagent (Stemcell tech, 05872).
-
bioRxiv - Genomics 2023Quote: ... Undifferentiated iPSCs were detached by a 4-min incubation with Accutase (StemCell technologies) and seeded onto Geltrex (Life Technologies)-coated plates at a density of 200,000 cells/cm2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 5,000 cells were re-suspended in 4 mL of Methocult media (STEMCELL Technologies). 1.1 mL of methocult-cell suspension was plated into a 6-well plate using 16-gauge blunt-end needles (STEMCELL Technologies) ...
-
bioRxiv - Neuroscience 2024Quote: ... EBs were cultured for 4 days in mTeSR™ Plus medium (STEMCELL Technologies), supplemented daily with 50 ng/mL bone morphogenetic protein 4 (BMP4) ...
-
bioRxiv - Cancer Biology 2024Quote: ... edited residual HSCs were added to 4 mL of MethoCult H4435 (Stemcell Technologies) and plated in triplicate ...
-
bioRxiv - Immunology 2021Quote: De-identified peripheral blood units were purchased from StemCell Technologies (Vancouver, Canada). Peripheral blood samples from 25 healthy donors (11 male and 14 female ...
-
bioRxiv - Cell Biology 2020Quote: ... were incubated overnight at 4° C with anti-CD3 (Clone UCHT1, StemCell Technologies, #60011) 10 μg/mL in PBS ...
-
bioRxiv - Genetics 2021Quote: ... iPSC cultures were passaged every 3-4 days with Accutase (Stem Cell Technologies, 07920) or ReLeSR (Stem Cell Technologies ...
-
bioRxiv - Developmental Biology 2023Quote: ... after which 4 ml maturation medium (Cerebral organoid kit, cat. n. 08570, StemCell Technologies) were gently added to each well ...
-
bioRxiv - Cell Biology 2023Quote: ... On days 4 and 6 LDM medium with added 50ng/ml BMP4 (STEMCELL Technologies) and 6ul/ml DMSO was used ...
-
bioRxiv - Cell Biology 2023Quote: ... Routine passaging was performed every 4-5 days using ReLeSR (Cat. # 05873; STEMCELL Technologies) according to manufacturer’s instructions in E8/VTN or by treatment with Collagenase IV (Cat ...
-
bioRxiv - Genomics 2021Quote: ... DE cultures were generated using the StemDiff Definitive Endoderm Kit (Stem Cell Technologies) as per manufacturer’s protocol for 5 days ...
-
bioRxiv - Genomics 2021Quote: ... and 4) one cord blood (CB001) collected with informed consent by StemCell Technologies (catalog #70007) (Table S1) ...
-
bioRxiv - Molecular Biology 2022Quote: ... Cells were passaged every 4 to 5 days using ReLeSR (StemCell Technologies, catalog no. 05872). We performed characterization of our iPSCs by immunofluorescence ...
-
bioRxiv - Cell Biology 2024Quote: ... The cells were passaged every 3-4 days by dissociating them using Accutase (STEMCELL Technologies) according to manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2023Quote: Primary cells are resuspended in a 3:4 solution of Mammocult medium (Stem Cell Technology) and Matrigel (Corning)17,26,29 ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were then treated with Wnt pathway inhibitor IWP-4 (5 μM) (Stemcell Technologies, #72552) for 48 hours followed by CM(- ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were passaged every 4 days by non-enzymatic dissociation with ReLeSR (StemCell Technologies Inc.) and plated at a density of 5.0×105 per 60 mm plate.
-
bioRxiv - Bioengineering 2023Quote: ... and passaged every 3-4 days using Gentle Cell Dissociation Reagent (STEMCELL Technologies, 100-0485) for clump passaging ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were then treated with Wnt pathway inhibitor IWP-4 (5 µM) (Stemcell Technologies, #72552) for 48 hours followed by CM(- ...
-
bioRxiv - Cancer Biology 2024Quote: 200-500 edited residual HSCs were added to 4 mL of MethoCult H4435 (Stemcell Technologies) and differentiated for 14 days ...
-
bioRxiv - Genetics 2024Quote: ... every other day and passaged every 3–4 days with Accutase (Stem Cell Technologies 07920) or ReLeSR (Stem Cell Technologies 100-0483) ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were dissociated with Gentle Cell Dissociation Reagent (STEMCELL Technologies 07174 and passaged 1:4 (C1) or 1:6 (C2 ...
-
bioRxiv - Cancer Biology 2021Quote: ... The cells were cultured in Mammocult media supplemented with 4 μg/ml Heparin (Stem Cell Technology), 0.5 μg/ml hydrocortisone and 10% Mammocult Proliferation Supplement (Stem Cell Technology) ...
-
bioRxiv - Bioengineering 2022Quote: Human iPSCs (IMR90-4; WiCell Research Institute) were maintained with mTeSR Plus (STEMCELL Technologies, 100-0276) on dishes coated with 9-10 μg/cm2 Growth Factor Reduced Matrigel (Corning ...
-
bioRxiv - Immunology 2021Quote: Human peripheral blood from de-identified healthy donors was purchased from STEMCELL Technologies (Vancouver, Canada), which collects and distributes de-identified human blood products with consent forms ...
-
bioRxiv - Developmental Biology 2021Quote: Unsorted cells at day 6 (4+2) of differentiation were cultured in MethoCult 04434 (Stem Cell Technologies) in 35 mm dishes ...
-
bioRxiv - Bioengineering 2022Quote: ... Both UC3-4 and UCS-2 hiPSCs were frozen in mFreSR medium (Stem Cell Technologies, Vancouver, Canada) and stored under cryogenic conditions in a vapor phase liquid nitrogen dewar ...
-
bioRxiv - Cancer Biology 2022Quote: ... at a density of 4-5×105 cells per well in Myelocult medium (H5100, Stem Cell Technology). In the morning ...
-
bioRxiv - Cell Biology 2021Quote: ... This was followed by cardiac specification using RPMI B27-containing 5 μM IWP-4 (Stem Cell Technologies) for another 3 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... at a density of 4-5×105 cells per well in Myelocult medium (H5100, Stem Cell Technology). On the morning ...
-
bioRxiv - Bioengineering 2023Quote: IMR90-4 hiPSCs (passages 45–60) purchased from WiCell were maintained in mTeSR1 (85850, Stem Cell Technologies) in 6-well cell culture plates (30006 ...
-
bioRxiv - Cell Biology 2023Quote: ... This was followed by cardiac specification using RPMI B27-containing 5 μM IWP-4 (Stem Cell Technologies) for another 3 days ...
-
bioRxiv - Immunology 2024Quote: Human peripheral blood leukopaks from de-identified healthy donors were purchased from STEMCELL Technologies (Vancouver, Canada). CD4+ T cells and CD8+ T cells were enriched using the EasySep Human CD4+ T Cell Isolation Kit and EasySep Human CD8+ T Cell Isolation Kit (STEMCELL Technologies) ...
-
bioRxiv - Microbiology 2023Quote: ... WA09 cells were differentiated to definitive endoderm (DE) using the STEMdiffTM Definitive Endoderm Kit (STEMCELL Technologies) according to the manufacturer’s protocol ...
-
bioRxiv - Genomics 2021Quote: ... tissue was viably frozen by placing 4 biopsies in 500 ml of CryoStor CS10 freezing media (STEMCELL Technologies). Tubes were inverted and then placed on ice for up to 30 minutes ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were cultured for 4 days using STEMdiff™ Definitive Endoderm Differentiation Kit (Cat. No. 05110, STEMCELL Technologies) for definitive endoderm induction ...
-
bioRxiv - Bioengineering 2022Quote: ... on 1:100 diluted Geltrex (Thermo Fisher)-coated plates with daily medium changes and passaging every 3-4 days with releasing agent ReLeSR (Stemcell Technologies).